National Lupus Outreach and Clinical Trial Education Initiative
Lupus is a chronic autoimmune disease that causes inflammation in various tissues of the body, which can lead to permanent damage. According to the U.S. Centers for Disease Control and Prevention, about 9 out of 10 people diagnosed with lupus are women between the ages of 15 and 44. African American, Hispanic/Latina, Asian American, American Indian/Alaska Native, and Native Hawaiian/Pacific Islander women are more likely to be diagnosed with lupus. Clinical trials play a key role in identifying and developing new and improved treatments for individuals with lupus.
On September 29, 2023, the U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH) awarded more than $1.9 million in grants to four organizations for its National Lupus Outreach and Clinical Trial Education Initiative. Over a three-year period, awardees will implement and sustain effective interventions to advance clinical trial diversity, and ultimately, reduce health disparities experienced by racial and ethnic minority individuals with lupus.
| Award Recipients | City | State | Amount |
|---|---|---|---|
| American College of Rheumatology | Atlanta | GA | $499,999 |
| Lupus Foundation of America, Inc. | Washington | DC | $500,000 |
| National Minority Quality Forum, Inc. | Washington | DC | $500,000 |
| The Trustees of Columbia University in the City of New York | New York | NY | $498,100 |
| Total: | $1,998,099 | ||
Date Last Reviewed: January 2026